These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7153873)

  • 1. Induction effect of phenobarbital on carbamazepine-10,11-epoxide kinetics in the rhesus monkey.
    Wedlund PJ; Patel IH; Levy RH
    J Pharmacokinet Biopharm; 1982 Aug; 10(4):427-35. PubMed ID: 7153873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction effect of phenobarbital on the carbamazepine to carbamazepine-10, 11-epoxide pathway in rhesus monkeys.
    Patel IH; Wedlund P; Levy RH
    J Pharmacol Exp Ther; 1981 Jun; 217(3):555-8. PubMed ID: 7229992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of carbamazepine and carbamazepine-10,11-epoxide on hepatic cytochromes P450 in the rat.
    Panesar SK; Bandiera SM; Abbott FS
    Drug Metab Dispos; 1996 Jun; 24(6):619-27. PubMed ID: 8781776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic study of carbamazepine and its epoxide metabolite in humans.
    Sumi M; Watari N; Umezawa O; Kaneniwa N
    J Pharmacobiodyn; 1987 Nov; 10(11):652-61. PubMed ID: 3446773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of phenobarbital on the pharmacokinetics of carbamazepine-10,11-epoxide, an active metabolite of carbamazepine.
    Spina E; Martines C; Fazio A; Trio R; Pisani F; Tomson T
    Ther Drug Monit; 1991 Mar; 13(2):109-12. PubMed ID: 2053116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of phenobarbital on carbamazepine and its major metabolites in serum, different brain areas, and urine after acute and chronic administration to rats.
    Mendez-Alvarez E; Soto-Otero R; Galan-Valiente J; Sierra-Marcuño G
    Epilepsia; 1990; 31(2):202-10. PubMed ID: 2318171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbamazepine metabolism in humans: effect of concurrent anticonvulsant therapy.
    Ramsay RE; McManus DQ; Guterman A; Briggle TV; Vazquez D; Perchalski R; Yost RA; Wong P
    Ther Drug Monit; 1990 May; 12(3):235-41. PubMed ID: 2112276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linear relationship between cytochrome P-450 and carbamazepine clearance in rhesus monkey.
    Wedlund PJ; Nelson SD; Nickelson S; Levy RH
    Drug Metab Dispos; 1982; 10(5):480-5. PubMed ID: 6128196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of carbamazepine and carbamazepine-epoxide, determined by use of plasma and saliva.
    Westenberg HG; van der Kleijn E; Oei TT; de Zeeuw RA
    Clin Pharmacol Ther; 1978 Mar; 23(3):320-8. PubMed ID: 627139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of phenobarbital and phenytoin with carbamazepine and its metabolites' concentrations, concentration ratios, and level/dose ratios in epileptic children.
    Liu H; Delgado MR
    Epilepsia; 1995 Mar; 36(3):249-54. PubMed ID: 7614908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free concentration of carbamazepine and carbamazepine-10,11-epoxide in children and adults. Influence of age and phenobarbitone co-medication.
    Riva R; Contin M; Albani F; Perucca E; Procaccianti G; Baruzzi A
    Clin Pharmacokinet; 1985; 10(6):524-31. PubMed ID: 4064451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbamazepine/valproic acid interaction in man and rhesus monkey.
    Levy RH; Moreland TA; Morselli PL; Guyot M; Brachet-Liermain A; Loiseau P
    Epilepsia; 1984 Jun; 25(3):338-45. PubMed ID: 6426944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-dose kinetics and metabolism of carbamazepine-10,11-epoxide.
    Tomson T; Tybring G; Bertilsson L
    Clin Pharmacol Ther; 1983 Jan; 33(1):58-65. PubMed ID: 6848300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition of carbamazepine and its 10,11-epoxide metabolite in the isolated perfused rat liver.
    Rane A; Shand DG; Wilkinson GR
    Drug Metab Dispos; 1977; 5(2):179-84. PubMed ID: 15811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of treatment with phenobarbital and stiripentol on carbamazepine-induced teratogenicity and reactive metabolite formation.
    Finnell RH; Bennett GD; Slattery JT; Amore BM; Bajpai M; Levy RH
    Teratology; 1995 Dec; 52(6):324-32. PubMed ID: 8711619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of valproic acid on metabolic clearance of carbamazepine epoxide.
    Ogiso T; Ito Y; Iwaki M; Horibe Y
    J Pharmacobiodyn; 1990 Apr; 13(4):238-45. PubMed ID: 2143532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of carbamazepine metabolism by cimetidine.
    Grasela DM; Rocci ML
    Drug Metab Dispos; 1984; 12(2):204-8. PubMed ID: 6144486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships between carbamazepine-diol, carbamazepine-epoxide, and carbamazepine total and free steady-state concentrations in epileptic patients: the influence of age, sex, and comedication.
    Svinarov DA; Pippenger CE
    Ther Drug Monit; 1996 Dec; 18(6):660-5. PubMed ID: 8946662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbamazepine-10,11-diol steady-state serum levels and renal excretion during carbamazepine therapy in adults and children.
    Bourgeois BF; Wad N
    Ther Drug Monit; 1984; 6(3):259-65. PubMed ID: 6506133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steady state pharmacokinetics of carbamazepine-phenobarbital interaction in patients with epilepsy.
    Sennoune S; Iliadis A; Bonneton J; Barra Y; Genton P; Mesdjian E
    Biopharm Drug Dispos; 1996 Mar; 17(2):155-64. PubMed ID: 8907722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.